Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.
Publications
View AllSummarizing systematic reviews
Umbrella reviews provide a ready means for decision makers in healthcare to gain a clear understanding of a broad topic area. The umbrella review methodology described here is t...
Assessing Publication Bias in Meta-Analysis
Given that publication bias can affect the validity of meta-analytic studies, researchers are encouraged to use more than one method to assess for bias so that clinicians and de...
Affiliated Researchers
Institution Info
- Type
- education
- Country
- TH
- Publications
- 4
- Citations
- 7,996
External Links
Identifiers
- ROR
- https://ror.org/05m2fqn25